Stephen Hart

Stephen Hart

University College London

H-index: 46

Europe-United Kingdom

About Stephen Hart

Stephen Hart, With an exceptional h-index of 46 and a recent h-index of 20 (since 2020), a distinguished researcher at University College London, specializes in the field of nanoparticles, gene therapy, siRNA, cystic fibrosis, neuroblastoma.

His recent articles reflect a diverse array of research interests and contributions to the field:

In vitro platform to model the function of ionocytes in the human airway epithelium

Topical gene editing therapeutics using lipid nanoparticles:‘gene creams’ for genetic skin diseases?

Lipid nanoparticles efficiently deliver the base editor ABE8e for COL7A1 correction in dystrophic epidermolysis bullosa fibroblasts in vitro.

Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing

Anionic nanocomplexes for nucleic acid delivery

BMI1 Transduction of Human Airway Epithelial Cells for Expansion of Proliferation and Differentiation

Expression of gain-of-function CFTR in cystic fibrosis airway cells restores epithelial function better than wild-type or codon-optimized CFTR

851 RNA therapy for congenital melanocytic naevi

Stephen Hart Information

University

Position

___

Citations(all)

6665

Citations(since 2020)

1574

Cited By

5591

hIndex(all)

46

hIndex(since 2020)

20

i10Index(all)

104

i10Index(since 2020)

50

Email

University Profile Page

Google Scholar

Stephen Hart Skills & Research Interests

nanoparticles

gene therapy

siRNA

cystic fibrosis

neuroblastoma

Top articles of Stephen Hart

In vitro platform to model the function of ionocytes in the human airway epithelium

Respiratory Research

2024/12

Topical gene editing therapeutics using lipid nanoparticles:‘gene creams’ for genetic skin diseases?

2024/5

Lipid nanoparticles efficiently deliver the base editor ABE8e for COL7A1 correction in dystrophic epidermolysis bullosa fibroblasts in vitro.

J Invest Dermatol

2024/4/5

Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing

Molecular Therapy-Methods & Clinical Development

2023/12/14

Anionic nanocomplexes for nucleic acid delivery

2023/10/24

BMI1 Transduction of Human Airway Epithelial Cells for Expansion of Proliferation and Differentiation

2023/10/20

Expression of gain-of-function CFTR in cystic fibrosis airway cells restores epithelial function better than wild-type or codon-optimized CFTR

Molecular Therapy-Methods & Clinical Development

2023/9/14

851 RNA therapy for congenital melanocytic naevi

Journal of Investigative Dermatology

2023/5/1

Development of in vitro transcribed mRNA therapeutics for cystic fibrosis

2019/8/1

K978C CFTR restores essential epithelial function with greater efficiency than wildtype CFTR when expressed in CF airway cells

bioRxiv

2022/8/13

Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivo

Journal of Controlled Release

2022/8/1

Composition, method and use thereof

2022/4/7

592: Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR/Cas9 gene editing

Journal of Cystic Fibrosis

2021/11/1

Higher throughput drug screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesia

European Respiratory Journal

2021/10/1

Integrin‐Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor‐Specific Delivery Achieve MYCN Silencing with Improved Survival

Advanced Functional Materials

2021/9

Lipids and complexes for the delivery of biologically-active material to cells

2021/8/24

Complex for the delivery of cas9 proteins and guide rna to cells

2021/8/12

Improved lipid-peptide nanocomplex formulation for mrna delivery to cells

2021/6/10

CRISPR/Cas9 gene editing therapies for cystic fibrosis

2021/6/3

Stephen Hart
Stephen Hart

H-Index: 23

Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers

2021/2/4

See List of Professors in Stephen Hart University(University College London)